Association of pretreatment neutrophil-to-lymphocyte ratio with clinical outcomes in cancer immunotherapy: An evidence synthesis from 30 meta-analyses
CONCLUSIONS: Elevated pretreatment NLR correlates with poor outcomes in cancer immunotherapy, suggesting its potential as a biomarker for identifying appropriate treatment populations and predicting clinical outcomes. Nevertheless, further validation through prospective cohort studies is warranted.PMID:38579566 | DOI:10.1016/j.intimp.2024.111936
Source: International Immunopharmacology - Category: Allergy & Immunology Authors: Haoyu Wang Ruiyuan Yang Dan Liu Weimin Li Source Type: research
More News: Allergy & Immunology | Cancer | Cancer & Oncology | Carcinoma | Databases & Libraries | Hepatocellular Carcinoma | Immunotherapy | Kidney Cancer | Liver Cancer | Lung Cancer | Melanoma | Non-Small Cell Lung Cancer | Renal Cell Carcinoma | Science | Skin Cancer | Statistics | Study